Metraipolis › archive › dc_4950660b74db

Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges — Europe PMC PMID:41712472

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41712472
DOI
10.1021/acs.analchem.5c06531
License (as archived)
solo-consultazione
Archived
2026-11-05T15:09:04.053Z
SHA-256 of the archived text
7a146e4c57d46ab01bf5b9ffa9b3e4eaffba910a301abeb1c102e293ce47cb49
Stable URL of this page
https://metraipolis.com/documento/dc_4950660b74db

How to cite

Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges — Europe PMC PMID:41712472 — Europe PMC (en), https://europepmc.org/article/MED/41712472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4950660b74db (Metraipolis archive dc_4950660b74db, sha256 7a146e4c57d46ab01bf5b9ffa9b3e4eaffba910a301abeb1c102e293ce47cb49)
BibTeX
@misc{dc4950660b74db,
  title = {Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges — Europe PMC PMID:41712472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41712472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4950660b74db; sha256 7a146e4c57d46ab01bf5b9ffa9b3e4eaffba910a301abeb1c102e293ce47cb49},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41712472. Agents can read the archived copy with the MCP tool read_document.